Atwater Malick’s Avanos Medical AVNS Stock Holding History

Atwater Malick’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-29	Closed	-$1K	–	48
2019 Q3	$1K	Buy	+29	New	+$1.11K	﹤0.01%	203

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

Atwater Malick's AVNS Position: Q4 2019 in Review

Atwater Malick sold out of Avanos Medical (AVNS) in Q4 2019, closing a stake of 29 shares — an estimated $1K sold.

Atwater Malick first reported a position in AVNS in Q3 2019 and held it in 1 quarter. The position peaked at $1K in Q3 2019. 293 funds tracked by Wall St. Rank hold AVNS as of Q4 2019.

Atwater Malick reported no remaining Avanos Medical position as of Q4 2019 after selling out during the quarter.
Atwater Malick sold 29 Avanos Medical shares in Q4 2019, an estimated $1K.
Atwater Malick first reported a position in Avanos Medical in Q3 2019 and held it in 1 quarter.
Atwater Malick's Avanos Medical position peaked at $1K in Q3 2019.
293 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2019.

Based on Atwater Malick's 13F filing for Q4 2019, filed 7 Jan 2020.